Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2017) 49 EP688 | DOI: 10.1530/endoabs.49.EP688

1Department of Medicine and Surgery, University of Insubria, Varese, Italy; 2Research Center for Endocrine Surgery, University of Insubria, Varese, Italy.


Obesity has become one of the greatest public health concerns and is known to be a major risk factor for cardiac, respiratory and metabolic diseases. Bariatric surgery is the most effective treatment for morbid obesity. According with guidelines, surgery is indicated for treatment of patients with BMI greater than 40 kg/m2 or above 35 kg/m2, with at least one obesity-related comorbid condition, such as as type 2 diabetes, hypertension, dyslipidemia, sleep apnea, osteoarthritis. Nowadays, sleeve gastrectomy is one of the most common techniques, able to cure metabolic disorders, allowing a shorter convalescence and fewer complications. We herein describe the baseline characteristics of 38 adults (35 women, mean age 41±13 years), suitable for surgery. Patients were referred by Surgeons or other Specialists such as Cardiologists, Pulmonologists, Nephrologists or Orthopedicians. Three patients were admitted for the conversion of laparoscopic adjustable gastric banding, to achieve additional weight loss. In keeping with guidelines, BMI was 43.3±6 Kg/m2 (71% ≥40 kg/m2, 23.5% 35–39.9 kg/m2, 5.3% <35 kg/m2), with a visceral pattern of obesity (waist circumference 123±11 cm). Half of the patients suffered from metabolic syndrome, defined according to IDF/AHA/NHLB harmonized definition. Actually, 29% had diabetes, 37% hypertension and 53% dyslipidemia. Among the others, arthropathy was the most frequent comorbidity (21%), followed by respiratory diseases (chronic obstructive or restrictive pulmonary disease, 19%), chronic venous insufficiency (11%) or heart diseases (5.3%). We observed gastric diseases in almost half of the population (44%), and, as expected, 24% had hiatal hernia. Beyond these, 71% of patients emerged to have thyroid disease, with a high prevalence of non-toxic goiter and Hashimoto’s thyroiditis. During the screening, papillary thyroid cancer was disclosed in two patients (5.3%). According to the literature, these data underscore the high prevalence of obesity-related morbilities and the need for an effective and urgent treatment.

Volume 49

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.